During the past decade, Park Ridge Hospital Breast Health Center conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 16 clinical trials were completed, i.e. on average, 160% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 13 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Park Ridge Hospital Breast Health Center" #1 sponsor was "SWOG Cancer Research Network" with 16 trials, followed by "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored, "Eastern Cooperative Oncology Group" with 1 trials sponsored, "Gynecologic Oncology Group" with 1 trials sponsored and "NSABP Foundation Inc" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Park Ridge Hospital Breast Health Center" #1 collaborator was "National Cancer Institute (NCI)" with 20 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 1 trials as a collaborator and "Roche-Genentech" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Park Ridge Hospital Breast Health Center" are "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (5 trials), "Breast Cancer" (3 trials), "Stage IV Squamous Cell Lung Carcinoma" (2 trials) and "Untreated Adult Acute Myeloid Leukemia" (2 trials). Many other conditions were trialed in "Park Ridge Hospital Breast Health Center" in a lesser frequency.

Most popular intervention types in "Park Ridge Hospital Breast Health Center" are "Drug" (18 trials), "Other" (15 trials), "Biological" (7 trials), "Procedure" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (9 trials), "Docetaxel" (4 trials), "placebo" (3 trials), "Cetuximab" (2 trials) and "Cytarabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Park Ridge Hospital Breast Health Center" are 16 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Park Ridge Hospital Breast Health Center". undefined are not yet recruiting, undefined are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Park Ridge Hospital Breast Health Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Park Ridge Hospital Breast Health Center, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Park Ridge Hospital Breast Health Center has several departments that took part in Clinical trials: "AdventHealth Infusion Center Asheville" - 59 trials